Sulindac (Healx)

舒林酸 (Healx)

Report date: 2026/01/22 16:42:01

Base Information

Drug NameSulindac (Healx)
Drug Alias Name舒林酸 (Healx研发新适应症)HLX-0201
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsFragile X Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHealx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHealx Ltd
Active IndicationsN/A
Inactive IndicationsFragile X Syndrome

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG